MER is most often overexpressed in haematological malignancies, including acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia, and mantle cell lymphoma, among others [28]. The gene discussed is MERTK; the disease is acute lymphoblastic leukemia.